National Physical Laboratory

Insights Issue 02


The pressure on research budgets in the healthcare and pharmaceutical sectors and the increase in the numbers of 'blockbuster' drugs coming off patent means the UK faces a significant challenge to remain a global leader in these areas.

In this issue of Insights, we focus on what the UK can do to remain a force in improving the provision of healthcare and its services across the world. In particular, we examine the benefit of collaboration between industry, government and academia, and look at how industrial engagement with the UK's research and science base can help accelerate innovation and commercialisation in healthcare.


Please note that the information will not be divulged to third parties, or used without your permission